Ambu Announces: Ready to Launch its New Display Technology for Single-Use Endoscopy

Section 2

Northwell Health Sends Vaccinators to Ecuador

At the request of Ecuador’s Minster of Health, and for the first time since the start of the pandemic, the Northwell Health CGH team traveled outside of the U.S. on June 13 to help get shots in arms relieve overburdened health care workers in the South American country who have been working around the clock in the race to vaccinate their population.

Fusion Marketplace Changes Healthcare Traveler Experience

Fusion Marketplace is a traveler-first driven platform giving healthcare professionals the power to make decisions in their careers that they haven't been able to in the past.

Ambu announced today that the Ambu® aView™ 2 Advance has now obtained CE mark and is listed at Food and Drug Administration which enables release for sale in Europe and North America by mid-May 2020. The aView 2 Advance is a portable full-HD display unit to be used together with our single-use endoscopes across multiple clinical specialties. Ambu, is a global manufacturer of medical devices, including single-use endoscopes.

“We have pioneered single-use endoscopy for more than ten years, and we now bring our portfolio to a new level of sophistication,” said Juan Jose Gonzalez, CEO of Ambu. “Image quality is critical for healthcare providers and patient diagnosis, and we can now offer a display unit that was not possible with a single-use endoscope just a few years ago. I believe we are raising the bar on innovative technology for hospitals and clinics.”

Jens Kemp, Ambu USA’s Vice President of Marketing said, the aView 2 Advance will fit the needs of clinicians throughout the hospital.

“Its mobile platform not only works well within the ICU, but specialists from other areas can use it to perform everything from cystoscopies to flexible laryngoscopies to bronchoscopies,” Kemp said. “It will increase workflow, efficiency and enable clinicians to address patients quickly.”

A reusable display for single-use devices

The aView 2 Advance is the display unit that clinicians connect a single-use scope into in order to transmit a live image from inside the human body. The scope is single-use and is discarded when the procedure is done – for hygienic, practical and economic reasons – while the display unit is reused as it has not been in contact with the patient.

“The aView 2 Advance seamlessly connects to the aScope family of sterile, single-use flexible endoscopes,” Kemp said. “A live image is displayed within seconds of powering on the monitor providing a high-quality image, with image capture and recording capability, in an easy to use, transportable monitor solution. After the procedure, health care providers can simply clean the monitor using commercially available disinfectant wipes widely used in healthcare.”

Technology for future product development

The aView 2 Advance covers Ambu’s existing endoscopes, which means that it can be used with a bronchoscope (for airway procedures), a rhinolaryngoscope (for ENT procedures) or a cystoscope (for urology procedures). The unit offers full-HD resolution, advanced image processing and an anti-reflective touchscreen. In addition, aView 2 Advance enables users to transfer recorded data to the hospital’s electronic health records (EHR).

The display unit is part of Ambu’s expansion across all major areas of endoscopy, and this technology platform will form the basis for the development of Ambu’s future single-use endoscope devices.

Built on a decade of experience

Ambu launched the world’s first single-use flexible bronchoscope, the Ambu® aScope™ in 2009. Ten years later, in 2019, over 600,000 Ambu single-use endoscopes were used in more than 3,500 hospitals making Ambu the world’s largest supplier of single-use endoscopes.



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles